SCHEMBL10046432

SCHEMBL10046432

CC(C)(C)c1c(NC(=O)[C@H]2CC2(C)C)cccc1NC(=O)[C@H]1CC1(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.46
AAK1 Q2M2I8 1/20 0.44
ACKR3 P25106 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
HTR1E P28566 1/20 0.36
HTT P42858 1/20 0.36
PAX8 Q06710 1/20 0.36
ATM Q13315 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
KDM4E B2RXH2 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CETP P11597 1/20 0.34
SRD5A2 P31213 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3438874 0.92 GAA (0.41) GAAAAK1ACKR3NPSR1CRHBP
SCHEMBL15120774 0.82 GAA (0.49) GAAAAK1NPSR1CRHBPCRHR2
SCHEMBL10084269 0.78 GAA (0.46) GAAAAK1ACKR3NPSR1CRHBP
SCHEMBL15119804 0.76 CETP (0.56) GAANPSR1KMT2ALMNAHPGD
SCHEMBL10046434 0.72 SMN1; SMN2 (0.58) GAAMEN1KMT2AMAPTHPGD
SCHEMBL3438878 0.71 CETP (0.58) NPSR1MEN1KMT2ALMNAMAPT
SCHEMBL10073854 0.71 HSD17B10 (0.64) MEN1KMT2ALMNAHPGDHTT
SCHEMBL10826670 0.69 GAA (0.43) GAAAAK1ACKR3NPSR1MEN1
SCHEMBL10046433 0.68 MDM4 (0.58) GAANPSR1MEN1KMT2ALMNA
SCHEMBL13999152 0.68 MAPT (0.50) GAAAAK1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130184456-A1 HETEROCYCLIC MACROCYCLE TEMPLATED METAL-ORGANIC MATERIALS UNIVERSITY OF SOUTH FLORIDA (US) 2013-07-18 US disclosed
US-20130030170-A1 ENANTIOSELECTIVE CYCLOPROPENATION OF ALKYNES UNIVERSITY OF SOUTH FLORIDA (US) 2013-01-31 US disclosed
US-20130023403-A1 METAL ORGANIC MATERIALS AS BIOMIMETIC ENZYMES UNIVERSITY OF SOUTH FLORIDA (US) 2013-01-24 US disclosed
US-20130023403-A1 METAL ORGANIC MATERIALS AS BIOMIMETIC ENZYMES UNIVERSITY OF SOUTH FLORIDA (US) 2013-01-24 US disclosed
US-20120077959-A1 Asymmetric Cobalt-Catalyzed Cyclopropanation With Succinimidyl Diazoacetate NATIONAL SCIENCE FOUNDATION 2012-03-29 US disclosed
US-20120077990-A1 Alkene Aziridination NATIONAL SCIENCE FOUNDATION 2012-03-29 US disclosed
US-20120077990-A1 Alkene Aziridination NATIONAL SCIENCE FOUNDATION 2012-03-29 US disclosed
US-20120046455-A1 Catalytic Cyclopropanation of Alkenes with Alpha-Cyano-Diazoacetates NATIONAL SCIENCE FOUNDATION 2012-02-23 US disclosed
US-8110699-B2 Cobalt-catalyzed asymmetric cyclopropanation of alkenes with α-nitrodiazoacetates UNIVERSITY OF SOUTH FLORIDA (US) 2012-02-07 US disclosed
US-8110699-B2 Cobalt-catalyzed asymmetric cyclopropanation of alkenes with α-nitrodiazoacetates UNIVERSITY OF SOUTH FLORIDA (US) 2012-02-07 US disclosed
US-20110207956-A1 INTRAMOLECULAR C-H AMINATION WITH PHOSPHORYL AZIDES NATIONAL SCIENCE FOUNDATION 2011-08-25 US disclosed
US-20100081838-A1 Cobalt-Catalyzed Asymmetric Cyclopropanation of Alkenes with alpha-Nitrodiazoacetates UNIVERSITY OF SOUTH FLORIDA (US) 2010-04-01 US disclosed
US-20100081838-A1 Cobalt-Catalyzed Asymmetric Cyclopropanation of Alkenes with alpha-Nitrodiazoacetates UNIVERSITY OF SOUTH FLORIDA (US) 2010-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046455-A1 Catalytic Cyclopropanation of Alkenes with Alpha-Cyano-Diazoacetates PPOX, POR, PCCA GAA 1559/4885AAK1 1236/4885ACKR3 3828/4885
US-20130030170-A1 ENANTIOSELECTIVE CYCLOPROPENATION OF ALKYNES CYCS, CBR3, HCCS GAA 4455/4885AAK1 3318/4885ACKR3 1044/4885
US-20110207956-A1 INTRAMOLECULAR C-H AMINATION WITH PHOSPHORYL AZIDES CYCS, CCNH, CBR3 GAA 2576/4885AAK1 2724/4885ACKR3 3607/4885
US-20130184456-A1 HETEROCYCLIC MACROCYCLE TEMPLATED METAL-ORGANIC MATERIALS ORC3, MCM4, MCM7 GAA 2248/4885AAK1 2117/4885ACKR3 1754/4885
US-20100081838-A1 Cobalt-Catalyzed Asymmetric Cyclopropanation of Alkenes with alpha-Nitrodiazoacetates PPOX, IDH3A, HMOX2 GAA 3727/4885AAK1 2304/4885ACKR3 1800/4885
US-20120077990-A1 Alkene Aziridination AZI2, PPOX, GLI2 GAA 2108/4885AAK1 881/4885ACKR3 3012/4885
US-20120077959-A1 Asymmetric Cobalt-Catalyzed Cyclopropanation With Succinimidyl Diazoacetate SI, STOM, SUCLA2 GAA 2601/4885AAK1 3456/4885ACKR3 1416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.